SCHEMBL1127643

SCHEMBL1127643

CC(C)[n+]1cccc2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
TNNI3 P19429 1/20 0.49
TNNT2 P45379 1/20 0.49
TNNC1 P63316 1/20 0.49
ACHE P22303 12/20 0.42
BCHE P06276 11/20 0.42
KDM4E B2RXH2 1/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
APOBEC3A P31941 1/20 0.40
KEAP1 Q14145 1/20 0.40
NFE2L2 Q16236 1/20 0.40
APOBEC3G Q9HC16 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL10482603 0.98 MEN1 (0.47) MEN1KMT2ATNNI3TNNT2TNNC1
SCHEMBL28816898 0.83 MEN1 (0.46) MEN1KMT2ATNNI3TNNT2TNNC1
Iodide SCHEMBL11372964 0.81 MEN1 (0.45) MEN1KMT2ATNNI3TNNT2TNNC1
Hydrochloric Acid SCHEMBL30920083 0.81 MEN1 (0.49) MEN1KMT2ATNNI3TNNT2TNNC1
SCHEMBL15631185 0.77 UGT2B7 (0.43) MEN1KMT2ATNNI3TNNT2TNNC1
SCHEMBL15631184 0.77 UGT2B7 (0.43) MEN1KMT2ATNNI3TNNT2TNNC1
SCHEMBL19425909 0.74 UGT2B7 (0.36) MEN1KMT2ATNNI3TNNT2TNNC1
Iodide SCHEMBL20636808 0.73 ACHE (0.64) MEN1KMT2AACHEKDM4EALDH1A1
SCHEMBL2332858 0.72 BCHE (0.46) ACHEBCHE
SCHEMBL20869480 0.71 MEN1 (0.32) MEN1KMT2ATNNI3TNNT2TNNC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4580855-A COOLING TO SOLIDIFY 7,7,8,8-TETRACYANOQUINODIMETHANE COMPLEX SALT SANYO ELECTRIC CO., LTD. (JP) 1986-04-08 US claimed
US-11696912-B2 Charged ion channel blockers and methods for use Nocion Therapeutics, Inc. (US) 2023-07-11 US disclosed
US-20200259085-A1 TREATMENT LIQUID CONTAINING IONIC COMPOUND, ORGANIC ELECTRONIC ELEMENT, AND METHOD FOR PRODUCING ORGANIC ELECTRONIC ELEMENT HITACHI CHEMICAL COMPANY, LTD. 2020-08-13 US disclosed
CN-106939074-B Treatment liquid containing ionic compound 日立化成株式会社 2020-06-16 CN disclosed
US-10665786-B2 Treatment liquid containing ionic compound, organic electronic element, and method for producing organic electronic element HITACHI CHEMICAL COMPANY, LTD. (JP) 2020-05-26 US disclosed
US-20200143954-A1 ORGANIC ELECTRONIC MATERIAL, POLYMERIZATION INITIATOR AND THERMAL POLYMERIZATION INITIATOR, INK COMPOSITION, ORGANIC THIN FILM AND PRODUCTION METHOD FOR SAME, ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, LIGHTING DEVICE, DISPLAY ELEMENT, AND DISPLAY DEVICE HITACHI CHEMICAL COMPANY, LTD. (JP) 2020-05-07 US disclosed
US-10566105-B2 Method for producing charge transport film HITACHI CHEMICAL COMPANY, LTD. (JP) 2020-02-18 US disclosed
US-20190100534-A1 Cephem Compounds with Latent Reactive Groups GLADIUS PHARMACEUTICALS INC (CA) 2019-04-04 US disclosed
US-20170349632-A1 QUINOLIUM CONJUGATES OF CYCLOSPORIN UCL BUSINESS PLC (GB) 2017-12-07 US disclosed
US-20170349632-A1 QUINOLIUM CONJUGATES OF CYCLOSPORIN UCL BUSINESS PLC (GB) 2017-12-07 US disclosed
US-20120181530-A1 MATERIAL FOR ORGANIC ELECTRONICS, ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY ELEMENT USING ORGANIC ELECTROLUMINESCENT ELEMENT, ILLUMINATING DEVICE, AND DISPLAY DEVICE RESONAC CORPORATION (JP) 2012-07-19 US disclosed
US-8034125-B2 Dye composition comprising at least one colorless disulfide/thiol precursor, and dyeing process using the composition L'OREAL S.A. (FR) 2011-10-11 US disclosed
US-20110190254-A1 CEPHALOSPORIN HAVING CATECHOL GROUP SHIONOGI & CO., LTD. (JP) 2011-08-04 US disclosed
US-20110039205-A1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOCURABLE COMPOSITION AND CURED BODY THEREOF SAN-APRO LIMITED (JP) 2011-02-17 US disclosed
EP-2284165-A1 PHOSPHONIUM SALT, PHOTOACID GENERATOR, PHOTO-CURABLE COMPOSITION, AND CURED PRODUCT OF THE PHOTO-CURABLE COMPOSITION San-Apro Limited (JP) 2011-02-16 EP disclosed
US-20110016642-A1 DYE COMPOSITION COMPRISING AT LEAST ONE COLORLESS DISULFIDE/THIOL PRECURSOR, AND DYEING PROCESS USING THE COMPOSITION L'OREAL S.A. (FR) 2011-01-27 US disclosed
US-7671206-B2 Synthesis and uses of pyroglutamic acid derivatives PRODIMED, S.A. (ES) 2010-03-02 US disclosed
US-20090163555-A1 SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES PRODIMED, S.A. (ES) 2009-06-25 US disclosed
US-20090163555-A1 SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES PRODIMED, S.A. (ES) 2009-06-25 US disclosed
US-20070249678-A1 SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES PRODIMED, S.A. (ES) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110016642-A1 DYE COMPOSITION COMPRISING AT LEAST ONE COLORLESS DISULFIDE/THIOL PRECURSOR, AND DYEING PROCESS USING THE COMPOSITION KRT18, SQOR, TST MEN1 4336/4885KMT2A 2387/4885TNNI3 2224/4885
US-20070249678-A1 SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES GLUL, RIMKLA, PHKG1 MEN1 869/4885KMT2A 579/4885TNNI3 3232/4885
US-20090163555-A1 SYNTHESIS AND USES OF PYROGLUTAMIC ACID DERIVATIVES GLUL, RIMKLA, GLS MEN1 841/4885KMT2A 513/4885TNNI3 3635/4885
US-20110190254-A1 CEPHALOSPORIN HAVING CATECHOL GROUP NRDC, LUC7L2, NR0B1 MEN1 2061/4885KMT2A 2780/4885TNNI3 2477/4885
US-20170349632-A1 QUINOLIUM CONJUGATES OF CYCLOSPORIN SHMT2, CS, SQOR MEN1 2807/4885KMT2A 4430/4885TNNI3 1386/4885
US-11696912-B2 Charged ion channel blockers and methods for use TRPV1, ASIC1, TRPA1 MEN1 2609/4885KMT2A 3122/4885TNNI3 582/4885
US-20110039205-A1 SULFONIUM SALT, PHOTOACID GENERATOR, AND PHOTOCURABLE COMPOSITION AND CURED BODY THEREOF ARSA, ASIC1, TST MEN1 2080/4885KMT2A 1227/4885TNNI3 3425/4885
US-20190100534-A1 Cephem Compounds with Latent Reactive Groups PGLS, GNE, COMT MEN1 3056/4885KMT2A 1073/4885TNNI3 2228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.